許家印稱恆大(03333.HK)4月銷售30.9億人幣 5月交樓目標10萬套
恆大(03333.HK)召開集團月度工作會議,主席許家印表示目前已實現562個保交樓項目正常施工、179個保交樓項目正在復工復產過程中。他指,集團努力實現所有保交樓項目全面正常施工,堅決完成5月10萬套的交樓目標。
他又提到,由去年9月至今年3月,公司每月銷售額僅兩三千萬元人民幣(下同),銷售已基本處於停止狀態。去年12月及今年2月集團兩次啟動銷售,都沒有成功,壓力之大不可想像。於今年4月初,集團第三次全面啟動營銷工作並成功,4月實現銷售30.9億元,相信銷售的恢復,對恆大、業主、上下游合作夥伴及所有債權人非常重要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.